Long read sequencing identifies complex structural variant landscape and recurrent TERT rearrangements in mucoepidermoid carcinoma
Elizabeth Gensterblum-Miller,Apurva Bhangale,Dana Al Majid,Victor Murcia Pienkowski,Malgorzata Rydzanicz,Joanna Janiszewska,Magdalena Kostrzewska-Poczekaj,Clifford Chang,Collin Brummel,Nicole L. Michmerhuizen,Jiayu Wang,Erin Sandford,Muneesh Tewari,Malgorzata Wierzbicka,Andrew C. Birkeland,Jonathan B. McHugh,Matthew E. Spector,Maciej Giefing,Malgorzata Jarmuz-Szymczak,Molly E. Heft Neal,J. Chad Brenner
DOI: https://doi.org/10.1016/j.oraloncology.2024.107108
IF: 5.972
2024-11-20
Oral Oncology
Abstract:Mucoepidermoid Carcinoma (MEC) is a common salivary malignant neoplasm. Approximately 60 % of MECs harbor translocations between CRTC1 or CRTC3 and MAML2 , which are thought to drive disease pathogenesis. However, the precise structural mechanism driving this rearrangement remains uncharacterized. Here, we performed multi-omic and long read genomic sequencing, discovering a chain of alterations that created the CRTC1::MAML2 fusion, but also an unexpected MAML2 to MYBL1 rearrangement, suggesting that MYBL1 may play a larger role in salivary gland cancers than previously recognized. Furthermore, we discovered and validated recurrent TERT rearrangements and amplifications in MEC models. 5/5 MEC cell lines and 36/39 (92 %) primary MEC tumors harbored a TERT rearrangement or copy number amplification. Custom sequencing of the TERT locus confirmed translocation breakpoints in 13/33 (39 %) MECs, while exome sequencing confirmed frequent TERT amplifications. Critically, TERT knockdown in NCI-H292, a cell line with TERT promoter rearrangement, reduced clonogenic cell survival, supporting a critical role of this gene in MEC tumorigenesis. Overall, our data suggest that complex chromothripsis rearrangement mechanisms drive the formation of structural variation in CRTC1::MAML2 fusion positive and negative tumors and reveal highly recurrent structural variation driving TERT rearrangement in MEC.
dentistry, oral surgery & medicine,oncology